Abstract
The current paper aims to study the effect of adenovirus-mediated IL-24 (Ad-IL-24) on human lung adenocarcinoma in vitro and in vivo and determine its possible mechanism of action. The growth-suppressing and apoptosis-inducing effects of Ad-IL-24, radiotherapy, and Ad-IL-24+ radiotherapy (hereinafter referred to as the joint group) on SPC-A1 lung carcinoma cells were assessed by using 3-(4,5-dimethyliazolyl-2)-2,5-diphnyltetrazolium bromide and flow cytometry. A human lung model was established with SPC-A1 cells in nude mice. Groups of mice were subjected to multi-point injections to their tumors. Gross tumor volumes were measured dynamically. The ratios of tumor suppression and radiosensitization effect were evaluated according to the method of probability sum Q values. The expressions of Bax, Bcl-2, Survivin, and Caspase-3 in tumor samples were detected by immunohistochemistry. The ratios of inhibition and apoptosis in the joint group were higher than those in the individual Ad-IL-24 and radiotherapy groups. In vitro, the joint group suppressed tumor growth conspicuously, showing a weight inhibition rate of about 64 %. The expressions of FasL, Bax and Caspase-3 were upregulated in the joint group, while the expressions of Cox,Bcl-2,VEGF,CD34 and Survivin were downregulated. The current study proves that Ad-IL-24 suppresses growth of SPC-A1 cells both in vitro and in vivo. Its functions appear to be related to cell apoptosis and antiangiogenesis.
Similar content being viewed by others
References
Swisher SG, Roth JA (2002) Clinical update of Ad-p53 gene therapy for lung cancer. Surg Oncol Clin N Am 11:521–535
Sainz-Perez A, Gary-Gouy H, Gaudin F, Maarof G, Marfaing-Koka A, de Revel T, Dalloul A (2008) IL-24 induces apoptosis of chronic lymphocytic leukemia B cells engaged into the cell cycle through dephosphorylation of STAT3 and stabilization of p53 expression. J Immunol 181:6051–6060
Sarkar D, Lebedeva IV, Gupta P, Emdad L, Sauane M, Dent P, Curiel DT, Fisher PB (2007) Melanoma differentiation associated gene-7 (mda-7)/IL-24: a magic bullet for cancer therapy? Expert Opin Biol Ther 7:577–586
Robson S, Pelengaris S, Khan M (2006) c-Myc and downstream targets in the pathogenesis and treatment of cancer. Recent Pat Anticancer Drug Discov 1:305–326
Pan XT, Sheng WH, Yang JC, Xie Y, Ye Z, Xiang J, Li D, Yang J (2008) Inhibition of pancreatic carcinoma growth by adenovirus-mediated human interleukin-24 expression in animal model. Cancer Biother Radio 23:425–434
Roy I, Holle L, Song W, Holle E, Wagner T, Yu X (2002) Efficient translocation and apoptosis induction by adenovirus encoded VP22-p53 fusion protein in human tumor cells in vitro. Anti-cancer Res 22:3185–3189
Xie YF, Sheng WH, Yang JC, Ye Z, Zhu Y, Chen X, Yang J (2008) Recombinant human IL-24 suppresses lung carcinoma cell growth via induction of cell apoptosis and inhibition of tumor angiogenesis. Cancer Biother Radio 23:310–320
Lebedeva IV, Su ZZ, Chang Y, Kitada S, Reed JC, Fisher PB (2002) The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells. Oncogene 21:708–718
Caudell EG, Mumm JB, Poiindexter N, Ekmekcioglu S, Mhashilkar AM, Yang XH, Retter MW, Hill P, Chada S, Grimm EA (2002) The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immuno-stimulatory activity and is designated IL-24. J Immunol 168:6041–6046
Mhashilkar AM, Schrock RD, Hindi M, Liao J, Sieger K, Kourouma F, Zu-Yang XH, Onishi E, Takh O, Vedvick TS, Fanger G, Stewart L, Watson GJ, Snary D, Fisher PB, Saeki T, Roth JA, Ramesh R, Chada S (2001) Melanoma differentiation associated gene-7 (mda-7): a novel antitumor gene for cancer gene therapy. Mol Med 7:271–282
Su ZZ, Lebedeva IV, Sarkar D, Gopalkrishnan RV, Sauane M, Sigmon C, Yacoub A, Valerie K, Dent P, Fisher PB (2003) Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner. Oncogene 22:1164–1180
Saeki T, Mhashilkar A, Swanson X, Zou-Yang XH, Sieger K, Kawabe S, Branch CD, Zumstein L, Meyn RE, Roth JA, Chada S, Ramesh R (2002) Inhibition of human lung cancer growth following adenovirus-mediated Mda-7 gene expression in vivo. Oncogene 21:4558–4566
Yuan SS, Chang HL, Chen HW, Kuo FC, Liaw CC, Su JH, Wu YC (2006) Selective cytotoxicity of squamocin on T24 bladder cancer cells at the S-phase via a Bax, Bad, and caspase-3 related pathways. Life Sci 78:869–874
Hengartner MO (2000) The biochemistry of apoptosis. Nature 407:770–776
Mercurio AM, Bachelder RE, Bates RC, Chung J (2004) Autocrine signaling in carcinoma: VEGF and the alpha6beta4 integrin. Semin Cancer Biol 14:115–122
Swamy MV, Herzog CR, Rao CV (2003) Inhibitor of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active P53. Cancer Res 63:5239–5242
Zhou XM, Wang BC, Fan XM, Zhang HB, Lin MC, Kung HF, Fan DM, Lam SK (2001) Non-steroidal anti-inflammatory drug induce apoptosis in gastric cancer cells through up-regulation of bax and bak. Carcinogenesis 22:1393–1397
Narayanan BA, Condon MS, Bosland MC, Narayanan NK, Reddy BS (2003) Suppression of N-methy-N-nitrosourea/testosterone-induced rat prostate cancer growth by celecoxib: effects on cyclooxygenase-2, cell cycle regulation, and apoptosis mechanism. Clin Cancer Res 9:3503–3513
Krysan K, Merhant FH, Zhu L, Dohadwala M, Luo J, Lin Y, Heuze-Vourc’h N, Põld M, Seligson D, Chia D, Goodglick L, Wang H, Strieter R, Sharma S, Dubinett S (2004) COX-2-dependent stabilization of survivin in non-small cell lung cancer. FASEB J 18:206–208
Nix P, Lind M, Greenman J, Stafford N, Cawkwell L (2004) Expression of COX-2 protein in radioresistant laryngeal cancer. Ann Oncol 15:797–801
Hou JQ, HE J, Wen DG, Chen ZX, Zeng J (2006) Surviving mRNA expression in urine as a biomarker for patients with transitional cell carcinoma of bladder. Chin Med J 119:1118–1120
Suzuki Y, Oka K, Yoshida D, Shirai K, Ohno T, Kato S, Tsujii H, Nakano T (2007) Correlation between survivin expression and locoregional control in cervical squamous cell carcinomas treated with radiation therapy. Gynecol Oncol 104:642–646
El-kott AF, El-baz MA, Mokhtar AA (2006) Proliferating cell nuclear antigen (PCNA) overexpression and microvessel density predict survival in the urinary bladder carcinoma. Int Urol Nephrol 38:237–242
Khmhoff M, Guan Y, Shappell HW, Davis L, Jack G, Shyr Y, Koch MO, Shappell SB, Breyer MD (2000) Enhanced expression of cyslooxygenase-2 in higher grade human transitional cell bladder carcinomas. Am J Pathol 157:29–35
Author information
Authors and Affiliations
Corresponding authors
Additional information
Dong Jiang and Shi-Ying Zheng have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Zheng, SY., Ge, JF., Zhao, J. et al. Adenovirus-mediated IL-24 confers radiosensitization to human lung adenocarcinoma in vitro and in vivo. Mol Biol Rep 42, 1069–1080 (2015). https://doi.org/10.1007/s11033-014-3846-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-014-3846-6